A Joint Model of Hormone Marker Variabilities to Predict Changes in Body Fat Distribution across the Menopausal Transition

Irena Chen , Max Planck Institute for Demographic Research (MPIDR)
Zhenke Wu, University of Michigan
Siobán D. Harlow, University of Michigan
Carrie A. Karvonen-Gutierrez, University of Michigan
Michelle M. Hood, University of Michigan
Michael Elliott, University of Michigan

Longitudinal biomarker data and cross-sectional outcomes are routinely collected in modern epidemiology studies, often with the goal of informing tailored early intervention decisions. For example, hormones such as estradiol (E2) and follicle-stimulating hormone (FSH) may predict changes in womens' health during the midlife. Most existing methods focus on constructing predictors from mean marker trajectories. However, subject-level biomarker variability may also provide critical information about disease risks and health outcomes. Current literature does not provide statistical models to investigate such relationships with valid uncertainty quantification. In this paper, we develop a fully Bayesian joint model that estimates subject-level means, variances, and co-variances of multiple longitudinal biomarkers and uses these as predictors to evaluate their respective associations with a cross-sectional health outcome. Simulations demonstrate excellent recovery of true model parameters. The proposed method provides less biased and more efficient estimates, relative to alternative approaches that either ignore subject-level differences in variances or perform two-stage estimation where estimated marker variances are treated as observed. Empowered by the model, analyses of women’s health data reveal, for the first time, that larger variability of E2 was associated with slower increases in waist circumference across the menopausal transition.

See paper

 Presented in Session P2. Health, Mortality, Ageing - Aperitivo